Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 11, 2026 15:15 ET | Source: Tevogen Bio Inc

Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Commitment During International Long COVID Awareness Month; Highlights Synergies of New Leadership Team and Digital Care Platform

Tevogen advances TVGN 489 for Long COVID, expanding HLA coverage to 65% of U.S. population and integrating digital monitoring capabilities.
March 11, 2026 11:38 ET | Source: Research and Markets

Balfaxar (Octapharma) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, & Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, March 11, 2026 (GLOBE NEWSWIRE) -- The "Balfaxar Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...
March 11, 2026 08:28 ET | Source: NurExone Biologic Inc

NurExone Announces Corporate Updates

TORONTO and HAIFA, Israel, March 11, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a biopharmaceutical company developing...
March 11, 2026 07:20 ET | Source: TIP Knowledge Services Pvt. Ltd.

Epigenetics Market to Surpass US $35.84 Billion by 2031, Fuelled by Rising Prevalence of Cancer - Latest Industry Research by The Insight Partners

Epigenetics Market is projected to grow from US$ 11.12 billion in 2024 to US$ 35.84 billion by 2031, registering a CAGR of 18.3%
March 11, 2026 06:39 ET | Source: SNS Insider pvt ltd

mRNA Therapeutics Market Size to Surpass USD 78.09 Billion by 2035 Caused by the Increasing Investment in Genetic Medicine Research Globally | SNS Insider

mRNA Therapeutics Market to grow from USD 16.19 Billion in 2025 to USD 78.09B by 2035 at 17.04% CAGR, driven by vaccine success, genetic medicine research.
March 10, 2026 10:21 ET | Source: Virtual Investor Conferences

Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th

NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the Life Sciences Virtual Investor...
March 10, 2026 09:00 ET | Source: Femasys Inc.

Femasys Advances FemBloc Toward U.S. Approval with Initiation of Pivotal Trial Enrollment

-- Enrollment begins in the FDA-authorized FINALE pivotal trial evaluating FemBloc, a first-of-its-kind non-surgical permanent birth control, following positive clinical data -- ATLANTA, March 10,...
March 10, 2026 09:00 ET | Source: Precipio, Inc.

Precipio Announces Publication of a Joint Study with Memorial Sloan-Kettering Cancer Center Highlighting Its Cutting-Edge Bloodhound BCR::ABL1 Assay

NEW HAVEN, Conn., March 10, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) has announced the publication1 in the Journal of Clinical Pathology of a study...
March 10, 2026 08:00 ET | Source: LENZ Therapeutics, Inc.

LENZ Therapeutics Announces Submission of Marketing Authorization Application to European Medicines Agency for VIZZ® for the Treatment of Presbyopia

MAA submission to the European Medicines Agency represents a key regulatory milestone in LENZ’s strategy to expand global access to VIZZ Submission of MAA in Europe results in the fifth ex-U.S....
March 10, 2026 06:48 ET | Source: Research and Markets

Lantidra (CellTrans) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, & Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, March 10, 2026 (GLOBE NEWSWIRE) -- The "Lantidra Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...